Product Information

TIMOLOL 0.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $26.3867 per ML under NDC 82260004525. Its NADAC has been published 55 times since Nov 5, 2025.

FDA first approved this application on Jun 4, 2004. Its Orange Book therapeutic-equivalence code is AT2.

The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIMOLOL 0.5% EYE DROP

Timolol Maleate
$26.3867per ML
High Outlier

Strength

5 mg/mL

NDC

82260004525

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TIMOLOL MALEATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021516

FDA Approved

6/4/2004

TE Code

AT2

On Market Since

6/23/2022

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TIMOLOL 0.5% EYE DROP has been published 55 times since Nov 5, 2025, and over the history we have for it it has risen 31.4%. The table below summarizes its recorded NADAC range and movement.

Current price$26.3867 per ML
All-time high$27.3522 (Nov 11, 2026)
All-time low$8.7027 (Dec 17, 2025)
52-week high$27.3522
52-week low$8.7027
Median price$11.3504
Average price$13.8431
Largest weekly change+46.9% (Aug 19, 2026)
Weeks tracked55
Tracking sinceNov 5, 2025

Price History

1W

-3.5%

1M

+21.0%

3M

+58.2%

6M

+135.3%

1Y

+98.5%

3Y

N/A

5Y

N/A

All

+31.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 33%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIMOLOL 0.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $26.3867 per ML (NDC 82260004525), effective Nov 18, 2026.

How has the price of TIMOLOL 0.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for TIMOLOL 0.5% EYE DROP has risen 31.4%. It has been tracked across 55 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% EYE DROP?

Since Nov 5, 2025, the NADAC for TIMOLOL 0.5% EYE DROP has ranged from a low of $8.7027 (Dec 17, 2025) to a high of $27.3522 (Nov 11, 2026), with a median of $11.3504 per ML.

Are there cheaper alternatives to TIMOLOL 0.5% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL 0.5% EYE DROP, is $17.7216 per ML — about 33% below TIMOLOL 0.5% EYE DROP.

Who manufactures TIMOLOL 0.5% EYE DROP?

TIMOLOL 0.5% EYE DROP (NDC 82260004525) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.